“…In recent years, tissue engineering has developed as an alternative regenerative medicine approach for the clinical treatment of severe skin diseases, as it allows the efficient treatment of large and deep skin conditions (Garzon et al, 2015;Kober et al, 2016). Numerous models of human skin, generated by tissue engineering, have been developed to date (Beaudoin Cloutier et al, 2017;Bhowmick et al, 2017;Forouzandeh et al, 2010;Hartmann-Fritsch et al, 2016;Klar et al, 2018;Larouche et al, 2016;Lloyd et al, 2015;Pensalfini et al, 2017;Reuter et al, 2017;Strong et al, 2017;Vig et al, 2017). However, few clinical trials have been conducted to test the biological security (phase I and II assays) of human skin models (Boa et al, 2013;Boyce et al, 2006;Boyce et al, 1999;Boyce et al, 2017;Germain et al, 2018;Moravvej et al, 2016;Yamada et al, 2012).…”